Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pulmonary Disease, Chronic Obstructive | 102 | 2023 | 3038 | 8.310 |
Why?
|
Pulmonary Emphysema | 57 | 2024 | 672 | 7.550 |
Why?
|
Tomography, X-Ray Computed | 128 | 2024 | 20086 | 4.770 |
Why?
|
Lung | 88 | 2024 | 9826 | 4.070 |
Why?
|
Lung Diseases, Interstitial | 24 | 2023 | 807 | 2.660 |
Why?
|
Smoking | 53 | 2023 | 8969 | 2.430 |
Why?
|
Respiratory Function Tests | 36 | 2021 | 1613 | 2.270 |
Why?
|
Pulmonary Artery | 17 | 2021 | 1911 | 2.200 |
Why?
|
Emphysema | 15 | 2024 | 247 | 2.090 |
Why?
|
Airway Remodeling | 10 | 2016 | 132 | 2.050 |
Why?
|
Forced Expiratory Volume | 44 | 2023 | 1741 | 2.020 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 14 | 2019 | 1183 | 1.500 |
Why?
|
Pneumonectomy | 9 | 2015 | 1093 | 1.400 |
Why?
|
Thorax | 6 | 2023 | 547 | 1.310 |
Why?
|
Pectoralis Muscles | 3 | 2021 | 82 | 1.130 |
Why?
|
Radiography, Thoracic | 9 | 2017 | 1265 | 1.100 |
Why?
|
Spirometry | 20 | 2021 | 862 | 1.070 |
Why?
|
Bronchography | 4 | 2013 | 74 | 1.040 |
Why?
|
Lung Diseases | 9 | 2022 | 1884 | 1.000 |
Why?
|
Pulmonary Veins | 7 | 2021 | 759 | 0.960 |
Why?
|
Bronchiectasis | 6 | 2022 | 128 | 0.900 |
Why?
|
Total Lung Capacity | 10 | 2016 | 143 | 0.840 |
Why?
|
Idiopathic Pulmonary Fibrosis | 5 | 2019 | 451 | 0.810 |
Why?
|
Pattern Recognition, Automated | 6 | 2020 | 996 | 0.790 |
Why?
|
Vital Capacity | 18 | 2022 | 922 | 0.770 |
Why?
|
Respiratory Mechanics | 6 | 2013 | 681 | 0.720 |
Why?
|
Pulmonary Heart Disease | 1 | 2019 | 36 | 0.710 |
Why?
|
Middle Aged | 139 | 2024 | 213127 | 0.670 |
Why?
|
Mucin-5B | 7 | 2019 | 141 | 0.650 |
Why?
|
Exercise Tolerance | 7 | 2022 | 770 | 0.640 |
Why?
|
Lung Diseases, Obstructive | 2 | 2021 | 316 | 0.630 |
Why?
|
Aged | 117 | 2023 | 162944 | 0.620 |
Why?
|
Severity of Illness Index | 40 | 2021 | 15530 | 0.610 |
Why?
|
Male | 160 | 2024 | 349538 | 0.610 |
Why?
|
Heart Ventricles | 5 | 2021 | 3801 | 0.600 |
Why?
|
Bronchi | 5 | 2022 | 840 | 0.590 |
Why?
|
Dyspnea | 6 | 2015 | 1298 | 0.590 |
Why?
|
Humans | 213 | 2024 | 742088 | 0.580 |
Why?
|
Female | 161 | 2024 | 379592 | 0.570 |
Why?
|
Aortic Diseases | 3 | 2012 | 741 | 0.570 |
Why?
|
Wolves | 1 | 2016 | 9 | 0.560 |
Why?
|
Lung Injury | 2 | 2019 | 436 | 0.560 |
Why?
|
Pulmonary Fibrosis | 6 | 2021 | 526 | 0.540 |
Why?
|
Bronchiolitis Obliterans | 2 | 2014 | 193 | 0.510 |
Why?
|
Aortography | 3 | 2015 | 431 | 0.500 |
Why?
|
Hypertension, Pulmonary | 7 | 2024 | 1527 | 0.490 |
Why?
|
Calcinosis | 3 | 2015 | 1497 | 0.490 |
Why?
|
Algorithms | 13 | 2020 | 13853 | 0.490 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2016 | 210 | 0.460 |
Why?
|
Longitudinal Studies | 25 | 2023 | 13921 | 0.450 |
Why?
|
Ventricular Dysfunction, Right | 4 | 2021 | 578 | 0.450 |
Why?
|
Mexican Americans | 1 | 2014 | 166 | 0.440 |
Why?
|
Reproducibility of Results | 22 | 2024 | 19862 | 0.440 |
Why?
|
Radiographic Image Enhancement | 6 | 2014 | 885 | 0.430 |
Why?
|
Bronchodilator Agents | 2 | 2014 | 502 | 0.420 |
Why?
|
Preoperative Period | 1 | 2014 | 546 | 0.410 |
Why?
|
Cohort Studies | 31 | 2022 | 40450 | 0.410 |
Why?
|
Asthma | 7 | 2022 | 5955 | 0.410 |
Why?
|
Disease Progression | 20 | 2021 | 13256 | 0.400 |
Why?
|
Organ Size | 7 | 2019 | 2253 | 0.400 |
Why?
|
Airway Obstruction | 5 | 2023 | 663 | 0.400 |
Why?
|
Imaging, Three-Dimensional | 6 | 2019 | 4029 | 0.390 |
Why?
|
Image Processing, Computer-Assisted | 9 | 2019 | 8925 | 0.380 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2012 | 186 | 0.380 |
Why?
|
Magnetic Resonance Imaging | 8 | 2018 | 35342 | 0.380 |
Why?
|
Pulmonary Valve | 1 | 2015 | 437 | 0.380 |
Why?
|
Absorptiometry, Photon | 1 | 2017 | 1726 | 0.380 |
Why?
|
Pulmonary Ventilation | 2 | 2009 | 372 | 0.380 |
Why?
|
Diagnostic Imaging | 4 | 2023 | 3507 | 0.360 |
Why?
|
Densitometry | 1 | 2010 | 156 | 0.360 |
Why?
|
Sensitivity and Specificity | 15 | 2017 | 14720 | 0.350 |
Why?
|
Genetic Predisposition to Disease | 15 | 2019 | 17400 | 0.350 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2009 | 107 | 0.340 |
Why?
|
Tomography, Optical Coherence | 2 | 2012 | 2637 | 0.330 |
Why?
|
Genome-Wide Association Study | 12 | 2020 | 12220 | 0.330 |
Why?
|
Linear Models | 11 | 2019 | 5948 | 0.310 |
Why?
|
Multivariate Analysis | 15 | 2019 | 12242 | 0.300 |
Why?
|
Positron-Emission Tomography | 2 | 2014 | 6259 | 0.290 |
Why?
|
Nutrition Surveys | 1 | 2014 | 1656 | 0.290 |
Why?
|
Regression Analysis | 9 | 2022 | 6452 | 0.290 |
Why?
|
Mucus | 3 | 2023 | 321 | 0.280 |
Why?
|
Trachea | 3 | 2013 | 1075 | 0.280 |
Why?
|
Aged, 80 and over | 33 | 2023 | 57683 | 0.270 |
Why?
|
Arteriosclerosis | 1 | 2010 | 1092 | 0.270 |
Why?
|
Predictive Value of Tests | 12 | 2020 | 15056 | 0.270 |
Why?
|
Hemodynamics | 2 | 2021 | 4197 | 0.260 |
Why?
|
Polymorphism, Genetic | 5 | 2017 | 4328 | 0.250 |
Why?
|
Genetic Loci | 4 | 2019 | 2572 | 0.250 |
Why?
|
Aorta, Thoracic | 1 | 2010 | 1080 | 0.240 |
Why?
|
Aorta | 3 | 2019 | 2057 | 0.240 |
Why?
|
Liver Transplantation | 1 | 2015 | 2117 | 0.230 |
Why?
|
Echocardiography | 3 | 2021 | 5097 | 0.230 |
Why?
|
Bronchitis, Chronic | 2 | 2014 | 62 | 0.230 |
Why?
|
Prognosis | 15 | 2023 | 29010 | 0.230 |
Why?
|
Pulmonary Embolism | 3 | 2021 | 2370 | 0.230 |
Why?
|
Case-Control Studies | 16 | 2020 | 21719 | 0.230 |
Why?
|
Niacin | 1 | 2023 | 116 | 0.220 |
Why?
|
Proportional Hazards Models | 11 | 2022 | 12344 | 0.210 |
Why?
|
Residual Volume | 3 | 2011 | 41 | 0.210 |
Why?
|
Observer Variation | 5 | 2017 | 2593 | 0.210 |
Why?
|
Pulmonary Diffusing Capacity | 3 | 2013 | 87 | 0.210 |
Why?
|
Tobacco Smoke Pollution | 3 | 2019 | 814 | 0.200 |
Why?
|
Azithromycin | 2 | 2014 | 195 | 0.200 |
Why?
|
Hospitalization | 4 | 2015 | 10232 | 0.200 |
Why?
|
Molecular Epidemiology | 2 | 2022 | 468 | 0.200 |
Why?
|
Posture | 1 | 2005 | 958 | 0.200 |
Why?
|
Phenotype | 14 | 2022 | 16331 | 0.190 |
Why?
|
Schistosomiasis | 1 | 2021 | 62 | 0.190 |
Why?
|
Lung Volume Measurements | 3 | 2013 | 377 | 0.190 |
Why?
|
Respiratory System Abnormalities | 1 | 2021 | 69 | 0.190 |
Why?
|
Respiratory Tract Diseases | 2 | 2018 | 722 | 0.190 |
Why?
|
Follow-Up Studies | 18 | 2022 | 39004 | 0.190 |
Why?
|
Environmental Exposure | 4 | 2019 | 4231 | 0.190 |
Why?
|
Thrombolytic Therapy | 2 | 2020 | 2161 | 0.190 |
Why?
|
Blood Vessels | 2 | 2018 | 1124 | 0.180 |
Why?
|
Fibrinolytic Agents | 2 | 2020 | 2156 | 0.180 |
Why?
|
Risk Factors | 23 | 2021 | 72145 | 0.180 |
Why?
|
Polymorphism, Single Nucleotide | 9 | 2019 | 15494 | 0.180 |
Why?
|
Adult | 33 | 2024 | 213712 | 0.180 |
Why?
|
Esophagus | 1 | 2005 | 1017 | 0.180 |
Why?
|
Exhalation | 3 | 2013 | 166 | 0.170 |
Why?
|
Tomography, Emission-Computed | 1 | 2022 | 1144 | 0.170 |
Why?
|
Survival Rate | 7 | 2021 | 12773 | 0.170 |
Why?
|
Sex Factors | 7 | 2020 | 10392 | 0.170 |
Why?
|
Logistic Models | 10 | 2019 | 13403 | 0.170 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2019 | 75 | 0.170 |
Why?
|
Risk Assessment | 10 | 2021 | 23320 | 0.160 |
Why?
|
Arthritis, Rheumatoid | 3 | 2023 | 3695 | 0.160 |
Why?
|
Phlebography | 1 | 2019 | 333 | 0.160 |
Why?
|
Prevalence | 13 | 2023 | 15194 | 0.160 |
Why?
|
Tidal Volume | 2 | 2011 | 489 | 0.160 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2014 | 5425 | 0.160 |
Why?
|
Respiratory System | 2 | 2019 | 555 | 0.160 |
Why?
|
Quality of Life | 9 | 2022 | 12730 | 0.160 |
Why?
|
Bronchoscopy | 2 | 2018 | 860 | 0.150 |
Why?
|
Muscular Atrophy | 1 | 2021 | 350 | 0.150 |
Why?
|
Retrospective Studies | 19 | 2024 | 77098 | 0.150 |
Why?
|
Therapy, Computer-Assisted | 1 | 2019 | 277 | 0.150 |
Why?
|
Mortality | 2 | 2019 | 2857 | 0.150 |
Why?
|
DNA | 3 | 2018 | 7289 | 0.150 |
Why?
|
Particulate Matter | 4 | 2019 | 2523 | 0.150 |
Why?
|
Pneumococcal Vaccines | 2 | 2012 | 390 | 0.150 |
Why?
|
Prospective Studies | 17 | 2024 | 53187 | 0.140 |
Why?
|
Cardiac Volume | 1 | 2017 | 210 | 0.140 |
Why?
|
Pleural Diseases | 1 | 2017 | 139 | 0.140 |
Why?
|
Promoter Regions, Genetic | 5 | 2019 | 5867 | 0.140 |
Why?
|
Radiation Dosage | 3 | 2019 | 1927 | 0.140 |
Why?
|
Pleura | 1 | 2017 | 235 | 0.130 |
Why?
|
Models, Economic | 1 | 2020 | 713 | 0.130 |
Why?
|
Clothing | 1 | 2016 | 92 | 0.130 |
Why?
|
Vasodilation | 1 | 2019 | 944 | 0.130 |
Why?
|
Tomography, Spiral Computed | 2 | 2014 | 279 | 0.130 |
Why?
|
Asbestos | 1 | 2017 | 251 | 0.130 |
Why?
|
Statistics as Topic | 3 | 2011 | 2372 | 0.130 |
Why?
|
Vasodilator Agents | 1 | 2019 | 976 | 0.130 |
Why?
|
Autophagy | 2 | 2013 | 1301 | 0.130 |
Why?
|
Cryopreservation | 1 | 2020 | 664 | 0.130 |
Why?
|
Postoperative Complications | 2 | 2014 | 15244 | 0.130 |
Why?
|
Ventricular Function | 1 | 2017 | 416 | 0.130 |
Why?
|
Cross-Sectional Studies | 9 | 2022 | 24913 | 0.130 |
Why?
|
Iceland | 3 | 2020 | 183 | 0.130 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 707 | 0.120 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2018 | 265 | 0.120 |
Why?
|
Galectin 3 | 1 | 2016 | 227 | 0.120 |
Why?
|
Respiratory Muscles | 1 | 2014 | 140 | 0.120 |
Why?
|
United States | 16 | 2021 | 69693 | 0.120 |
Why?
|
Muscle Strength | 1 | 2018 | 586 | 0.120 |
Why?
|
Antirheumatic Agents | 1 | 2023 | 1335 | 0.120 |
Why?
|
Endotoxins | 1 | 2016 | 525 | 0.120 |
Why?
|
Blood Volume | 1 | 2015 | 565 | 0.110 |
Why?
|
ROC Curve | 4 | 2017 | 3528 | 0.110 |
Why?
|
Artificial Intelligence | 2 | 2022 | 2187 | 0.110 |
Why?
|
Oxygen Consumption | 3 | 2022 | 1869 | 0.110 |
Why?
|
Radiography | 6 | 2016 | 7010 | 0.110 |
Why?
|
Sheep | 1 | 2016 | 1437 | 0.110 |
Why?
|
Busulfan | 1 | 2014 | 262 | 0.110 |
Why?
|
Body Mass Index | 7 | 2021 | 12695 | 0.110 |
Why?
|
Gene Expression Regulation | 4 | 2019 | 12071 | 0.110 |
Why?
|
Nitric Oxide | 2 | 2019 | 2128 | 0.110 |
Why?
|
Seasons | 1 | 2019 | 1492 | 0.110 |
Why?
|
Drug Monitoring | 1 | 2018 | 956 | 0.110 |
Why?
|
Odds Ratio | 3 | 2021 | 9846 | 0.110 |
Why?
|
Exercise Test | 5 | 2022 | 2075 | 0.110 |
Why?
|
Temperature | 1 | 2019 | 2207 | 0.100 |
Why?
|
Adenocarcinoma | 2 | 2023 | 6347 | 0.100 |
Why?
|
Phantoms, Imaging | 4 | 2017 | 2466 | 0.100 |
Why?
|
Contrast Media | 3 | 2014 | 5295 | 0.100 |
Why?
|
Simvastatin | 1 | 2014 | 360 | 0.100 |
Why?
|
Pulmonary Circulation | 1 | 2014 | 739 | 0.100 |
Why?
|
Pulmonary Edema | 1 | 2014 | 415 | 0.100 |
Why?
|
Dilatation, Pathologic | 1 | 2012 | 520 | 0.100 |
Why?
|
Subcutaneous Fat | 1 | 2014 | 391 | 0.100 |
Why?
|
Fibrinogen | 1 | 2014 | 894 | 0.100 |
Why?
|
Lipoxygenase Inhibitors | 1 | 2011 | 94 | 0.100 |
Why?
|
Inhalation Exposure | 1 | 2013 | 443 | 0.090 |
Why?
|
Bronchioles | 1 | 2010 | 25 | 0.090 |
Why?
|
Normal Distribution | 1 | 2011 | 280 | 0.090 |
Why?
|
Cysts | 1 | 2015 | 676 | 0.090 |
Why?
|
Thymus Gland | 1 | 2015 | 1264 | 0.090 |
Why?
|
Acute Disease | 5 | 2021 | 7141 | 0.090 |
Why?
|
Population Surveillance | 1 | 2021 | 2616 | 0.090 |
Why?
|
Vehicle Emissions | 1 | 2015 | 665 | 0.090 |
Why?
|
Orthomyxoviridae Infections | 3 | 1997 | 248 | 0.090 |
Why?
|
Cilia | 1 | 2013 | 463 | 0.090 |
Why?
|
Chi-Square Distribution | 3 | 2011 | 3510 | 0.090 |
Why?
|
Biological Products | 1 | 2018 | 856 | 0.090 |
Why?
|
Leukocytes | 1 | 2018 | 2039 | 0.090 |
Why?
|
Comorbidity | 6 | 2017 | 10372 | 0.090 |
Why?
|
Body Composition | 2 | 2021 | 2400 | 0.090 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2015 | 1239 | 0.090 |
Why?
|
Hydroxyurea | 1 | 2011 | 290 | 0.090 |
Why?
|
Cause of Death | 2 | 2020 | 3571 | 0.090 |
Why?
|
Toll-Like Receptors | 1 | 2013 | 592 | 0.090 |
Why?
|
Walking | 3 | 2013 | 1177 | 0.090 |
Why?
|
Age Factors | 8 | 2021 | 18355 | 0.090 |
Why?
|
Boston | 3 | 2017 | 9305 | 0.080 |
Why?
|
Toll-Like Receptor 4 | 1 | 2012 | 561 | 0.080 |
Why?
|
Research Design | 2 | 2023 | 5979 | 0.080 |
Why?
|
Demography | 1 | 2014 | 1650 | 0.080 |
Why?
|
Air Pollution | 2 | 2019 | 2284 | 0.080 |
Why?
|
Histone Deacetylases | 1 | 2013 | 729 | 0.080 |
Why?
|
Fibroblasts | 1 | 2019 | 4143 | 0.080 |
Why?
|
Perfusion Imaging | 1 | 2010 | 195 | 0.080 |
Why?
|
Hemagglutinins, Viral | 3 | 1997 | 67 | 0.080 |
Why?
|
Endothelium, Vascular | 1 | 2021 | 4455 | 0.080 |
Why?
|
Health Services | 1 | 2013 | 758 | 0.080 |
Why?
|
Referral and Consultation | 1 | 2021 | 3527 | 0.080 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2011 | 363 | 0.080 |
Why?
|
Helium | 1 | 2008 | 121 | 0.080 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2014 | 3239 | 0.080 |
Why?
|
Williams Syndrome | 1 | 2010 | 187 | 0.080 |
Why?
|
Occupational Diseases | 1 | 2016 | 1472 | 0.080 |
Why?
|
Superoxide Dismutase | 1 | 2010 | 596 | 0.080 |
Why?
|
Pneumococcal Infections | 1 | 2012 | 496 | 0.080 |
Why?
|
Receptors, Nicotinic | 1 | 2011 | 497 | 0.080 |
Why?
|
Pulmonary Wedge Pressure | 2 | 2024 | 264 | 0.080 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2014 | 1517 | 0.070 |
Why?
|
Gastroesophageal Reflux | 1 | 2014 | 782 | 0.070 |
Why?
|
Inflammasomes | 1 | 2012 | 493 | 0.070 |
Why?
|
Patient Selection | 2 | 2010 | 4214 | 0.070 |
Why?
|
Transplantation Conditioning | 1 | 2014 | 1597 | 0.070 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2013 | 1119 | 0.070 |
Why?
|
Analysis of Variance | 3 | 2011 | 6365 | 0.070 |
Why?
|
Critical Illness | 1 | 2019 | 2665 | 0.070 |
Why?
|
Genotype | 7 | 2018 | 12946 | 0.070 |
Why?
|
Ultrasonography | 1 | 2019 | 5978 | 0.070 |
Why?
|
Young Adult | 6 | 2023 | 56350 | 0.070 |
Why?
|
Elasticity Imaging Techniques | 1 | 2011 | 388 | 0.070 |
Why?
|
Occupational Exposure | 1 | 2016 | 1794 | 0.070 |
Why?
|
Vascular Diseases | 1 | 2014 | 1155 | 0.070 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13019 | 0.060 |
Why?
|
Tobacco Use Disorder | 1 | 2011 | 685 | 0.060 |
Why?
|
Pulmonary Medicine | 1 | 2007 | 213 | 0.060 |
Why?
|
Social Class | 1 | 2014 | 1995 | 0.060 |
Why?
|
Anti-Bacterial Agents | 2 | 2014 | 7153 | 0.060 |
Why?
|
Cytoskeletal Proteins | 1 | 2010 | 1363 | 0.060 |
Why?
|
Genetic Association Studies | 1 | 2014 | 2699 | 0.060 |
Why?
|
Adiposity | 1 | 2014 | 1806 | 0.060 |
Why?
|
Genome, Human | 1 | 2018 | 4420 | 0.060 |
Why?
|
Risk | 1 | 2017 | 9679 | 0.060 |
Why?
|
Aging | 2 | 2021 | 8626 | 0.060 |
Why?
|
Air Pollutants | 2 | 2019 | 2814 | 0.060 |
Why?
|
DNA Methylation | 1 | 2018 | 4282 | 0.060 |
Why?
|
Data Interpretation, Statistical | 2 | 2011 | 2714 | 0.060 |
Why?
|
Gene Expression | 2 | 2014 | 7790 | 0.060 |
Why?
|
Cluster Analysis | 3 | 2019 | 2713 | 0.060 |
Why?
|
Incidence | 5 | 2017 | 20928 | 0.060 |
Why?
|
Heart Diseases | 1 | 2017 | 2789 | 0.060 |
Why?
|
Ozone | 2 | 2019 | 469 | 0.060 |
Why?
|
Manometry | 1 | 2005 | 444 | 0.060 |
Why?
|
Cystic Fibrosis | 1 | 2012 | 1178 | 0.060 |
Why?
|
Self Report | 1 | 2014 | 3548 | 0.060 |
Why?
|
Age of Onset | 3 | 2015 | 3266 | 0.060 |
Why?
|
Image Enhancement | 2 | 2011 | 2921 | 0.050 |
Why?
|
C-Reactive Protein | 1 | 2014 | 3766 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2014 | 4379 | 0.050 |
Why?
|
Models, Statistical | 2 | 2015 | 5100 | 0.050 |
Why?
|
Traction | 1 | 2022 | 106 | 0.050 |
Why?
|
Administration, Inhalation | 2 | 2019 | 1104 | 0.050 |
Why?
|
Sex Distribution | 3 | 2014 | 2295 | 0.050 |
Why?
|
Area Under Curve | 2 | 2016 | 1653 | 0.050 |
Why?
|
Nerve Tissue Proteins | 2 | 2014 | 4465 | 0.050 |
Why?
|
Niacinamide | 1 | 2023 | 416 | 0.050 |
Why?
|
Graft vs Host Disease | 1 | 2014 | 2951 | 0.050 |
Why?
|
Angiography | 2 | 2019 | 1636 | 0.050 |
Why?
|
Software | 2 | 2020 | 4434 | 0.050 |
Why?
|
Apoptosis | 2 | 2014 | 9715 | 0.050 |
Why?
|
Oxygen | 2 | 2023 | 4169 | 0.050 |
Why?
|
Myocardium | 1 | 2014 | 4775 | 0.050 |
Why?
|
Mothers | 1 | 2011 | 2163 | 0.050 |
Why?
|
Heart | 1 | 2014 | 4462 | 0.050 |
Why?
|
Stroke Volume | 3 | 2022 | 4983 | 0.050 |
Why?
|
TATA Box Binding Protein-Like Proteins | 1 | 2019 | 8 | 0.050 |
Why?
|
Catheterization | 1 | 2005 | 1468 | 0.050 |
Why?
|
Magnetic Resonance Imaging, Cine | 2 | 2017 | 964 | 0.050 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2021 | 176 | 0.040 |
Why?
|
Quantitative Trait Loci | 2 | 2018 | 2015 | 0.040 |
Why?
|
beta Karyopherins | 1 | 2019 | 47 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 2915 | 0.040 |
Why?
|
Artifacts | 2 | 2019 | 1903 | 0.040 |
Why?
|
Time Factors | 5 | 2019 | 40054 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2013 | 4438 | 0.040 |
Why?
|
Cytokines | 1 | 2014 | 7317 | 0.040 |
Why?
|
APACHE | 1 | 2019 | 277 | 0.040 |
Why?
|
Heart Failure | 1 | 2022 | 10856 | 0.040 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2018 | 33 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2012 | 5019 | 0.040 |
Why?
|
Treatment Outcome | 7 | 2019 | 62966 | 0.040 |
Why?
|
Vascular Resistance | 1 | 2021 | 936 | 0.040 |
Why?
|
Occupations | 1 | 2020 | 517 | 0.040 |
Why?
|
Microtubule-Associated Proteins | 2 | 2013 | 1086 | 0.040 |
Why?
|
Residence Characteristics | 2 | 2019 | 2049 | 0.040 |
Why?
|
Activin Receptors, Type I | 1 | 2018 | 142 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 3862 | 0.040 |
Why?
|
Cells, Cultured | 4 | 2014 | 19223 | 0.040 |
Why?
|
Bronchial Arteries | 1 | 2016 | 20 | 0.040 |
Why?
|
Animals | 11 | 2017 | 168561 | 0.040 |
Why?
|
Treatment Failure | 2 | 2014 | 2615 | 0.040 |
Why?
|
Galactosides | 1 | 1996 | 50 | 0.030 |
Why?
|
Telomere | 1 | 2022 | 909 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2021 | 1184 | 0.030 |
Why?
|
Antibodies, Heterophile | 1 | 1996 | 126 | 0.030 |
Why?
|
Carbon | 1 | 2019 | 686 | 0.030 |
Why?
|
Pulmonary Surfactant-Associated Protein D | 1 | 2015 | 48 | 0.030 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2019 | 448 | 0.030 |
Why?
|
Reference Standards | 1 | 2019 | 1020 | 0.030 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2015 | 58 | 0.030 |
Why?
|
Health Status | 3 | 2013 | 4030 | 0.030 |
Why?
|
Calibration | 1 | 2017 | 815 | 0.030 |
Why?
|
Mice, Inbred C57BL | 4 | 2014 | 21821 | 0.030 |
Why?
|
Mice | 10 | 2017 | 81045 | 0.030 |
Why?
|
Microcirculation | 1 | 2019 | 1285 | 0.030 |
Why?
|
Qualitative Research | 1 | 2023 | 2680 | 0.030 |
Why?
|
snRNP Core Proteins | 1 | 2014 | 22 | 0.030 |
Why?
|
alpha-Mannosidase | 1 | 2014 | 20 | 0.030 |
Why?
|
Mannosidases | 1 | 2014 | 22 | 0.030 |
Why?
|
Drug Administration Schedule | 2 | 2014 | 4929 | 0.030 |
Why?
|
Mass Screening | 1 | 2010 | 5238 | 0.030 |
Why?
|
Sex Characteristics | 2 | 2015 | 2585 | 0.030 |
Why?
|
Oligosaccharides | 1 | 1996 | 414 | 0.030 |
Why?
|
Dynamins | 1 | 2014 | 152 | 0.030 |
Why?
|
Influenza A virus | 1 | 1997 | 456 | 0.030 |
Why?
|
Phenylbutyrates | 1 | 2013 | 69 | 0.030 |
Why?
|
Air Pollutants, Occupational | 1 | 2016 | 408 | 0.030 |
Why?
|
Thiolester Hydrolases | 1 | 2014 | 86 | 0.030 |
Why?
|
Inhalation | 1 | 2013 | 143 | 0.030 |
Why?
|
United States Environmental Protection Agency | 1 | 2013 | 139 | 0.030 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2014 | 297 | 0.030 |
Why?
|
RNA Helicases | 1 | 2014 | 142 | 0.030 |
Why?
|
Spain | 1 | 2014 | 465 | 0.030 |
Why?
|
Automation | 1 | 2015 | 584 | 0.030 |
Why?
|
Smoke | 1 | 2014 | 226 | 0.030 |
Why?
|
N-Acetylglucosaminyltransferases | 1 | 2014 | 171 | 0.030 |
Why?
|
Radiology | 1 | 2007 | 2090 | 0.030 |
Why?
|
Quinazolinones | 1 | 2014 | 221 | 0.030 |
Why?
|
Epigenomics | 1 | 2018 | 902 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2015 | 552 | 0.030 |
Why?
|
Length of Stay | 2 | 2019 | 6294 | 0.030 |
Why?
|
Sirtuin 1 | 1 | 2013 | 244 | 0.030 |
Why?
|
Antilymphocyte Serum | 1 | 2014 | 491 | 0.030 |
Why?
|
Carbon Monoxide | 1 | 2015 | 531 | 0.030 |
Why?
|
Immunoglobulin G | 2 | 2012 | 4554 | 0.030 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2013 | 962 | 0.030 |
Why?
|
Thigh | 1 | 2013 | 247 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2012 | 964 | 0.020 |
Why?
|
Caspase 1 | 1 | 2012 | 223 | 0.020 |
Why?
|
Leukotriene E4 | 1 | 2011 | 79 | 0.020 |
Why?
|
Chemokines | 1 | 2015 | 954 | 0.020 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2013 | 364 | 0.020 |
Why?
|
Bleomycin | 1 | 2012 | 499 | 0.020 |
Why?
|
Forced Expiratory Flow Rates | 1 | 2010 | 74 | 0.020 |
Why?
|
Observation | 1 | 2012 | 312 | 0.020 |
Why?
|
Serpin E2 | 1 | 2010 | 48 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2013 | 939 | 0.020 |
Why?
|
Cytosol | 1 | 2013 | 901 | 0.020 |
Why?
|
Macrolides | 1 | 2011 | 201 | 0.020 |
Why?
|
Blood Gas Analysis | 1 | 2011 | 381 | 0.020 |
Why?
|
Antigen Presentation | 1 | 1996 | 1284 | 0.020 |
Why?
|
China | 1 | 2016 | 2246 | 0.020 |
Why?
|
Pulmonary Alveoli | 1 | 2013 | 675 | 0.020 |
Why?
|
Caspase 3 | 1 | 2012 | 759 | 0.020 |
Why?
|
Necrosis | 1 | 2014 | 1643 | 0.020 |
Why?
|
Elastic Modulus | 1 | 2011 | 213 | 0.020 |
Why?
|
Leukotriene B4 | 1 | 2011 | 293 | 0.020 |
Why?
|
Cell Survival | 1 | 2020 | 5872 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2022 | 3656 | 0.020 |
Why?
|
Netherlands | 1 | 2014 | 2170 | 0.020 |
Why?
|
Epoxide Hydrolases | 1 | 2010 | 122 | 0.020 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2010 | 321 | 0.020 |
Why?
|
Antibodies, Viral | 2 | 1997 | 3164 | 0.020 |
Why?
|
Health Surveys | 1 | 2019 | 4030 | 0.020 |
Why?
|
Intention to Treat Analysis | 1 | 2010 | 425 | 0.020 |
Why?
|
Antibodies, Monoclonal | 2 | 1997 | 9274 | 0.020 |
Why?
|
Ubiquitination | 1 | 2013 | 1011 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2023 | 11001 | 0.020 |
Why?
|
Organ Specificity | 1 | 2014 | 2003 | 0.020 |
Why?
|
Education | 1 | 2012 | 543 | 0.020 |
Why?
|
Nasopharynx | 1 | 2011 | 379 | 0.020 |
Why?
|
Functional Residual Capacity | 1 | 2008 | 68 | 0.020 |
Why?
|
Internationality | 1 | 2014 | 1002 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2018 | 1899 | 0.020 |
Why?
|
Propensity Score | 1 | 2015 | 1771 | 0.020 |
Why?
|
Elastin | 1 | 2010 | 305 | 0.020 |
Why?
|
Isotopes | 1 | 2008 | 123 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2019 | 2566 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2013 | 789 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2013 | 1158 | 0.020 |
Why?
|
tau Proteins | 1 | 2018 | 1860 | 0.020 |
Why?
|
Drug Synergism | 1 | 2012 | 1791 | 0.020 |
Why?
|
Alabama | 1 | 2007 | 98 | 0.020 |
Why?
|
Genetic Markers | 1 | 2014 | 2633 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5385 | 0.020 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2013 | 1333 | 0.020 |
Why?
|
Protein Kinases | 1 | 2014 | 1638 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10248 | 0.020 |
Why?
|
Autoantibodies | 1 | 2015 | 2036 | 0.020 |
Why?
|
Lymphocyte Activation | 2 | 2014 | 5519 | 0.020 |
Why?
|
Phagocytosis | 1 | 2012 | 1538 | 0.020 |
Why?
|
Rest | 1 | 2011 | 900 | 0.020 |
Why?
|
Alleles | 1 | 2017 | 6931 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2014 | 4742 | 0.020 |
Why?
|
Reference Values | 1 | 2013 | 4982 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2014 | 3612 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2019 | 5310 | 0.020 |
Why?
|
Computer Simulation | 1 | 2019 | 6191 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 1989 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9185 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2014 | 1847 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2010 | 1995 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 2010 | 1400 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 7901 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2014 | 1860 | 0.020 |
Why?
|
Anticoagulants | 1 | 2020 | 4595 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2014 | 1788 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 1997 | 4664 | 0.010 |
Why?
|
Neutralization Tests | 2 | 1997 | 758 | 0.010 |
Why?
|
Drug Resistance, Bacterial | 1 | 2011 | 1032 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2014 | 6483 | 0.010 |
Why?
|
Streptococcus pneumoniae | 1 | 2009 | 712 | 0.010 |
Why?
|
Probability | 1 | 2009 | 2502 | 0.010 |
Why?
|
Electrocardiography | 1 | 2017 | 6440 | 0.010 |
Why?
|
Gene Frequency | 1 | 2010 | 3587 | 0.010 |
Why?
|
Registries | 1 | 2019 | 8077 | 0.010 |
Why?
|
Immunoglobulin E | 1 | 2009 | 1460 | 0.010 |
Why?
|
Bacterial Infections | 1 | 2011 | 1389 | 0.010 |
Why?
|
Lipids | 1 | 2014 | 3302 | 0.010 |
Why?
|
Genomics | 1 | 2018 | 5692 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2013 | 3678 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2012 | 3081 | 0.010 |
Why?
|
Mitochondria | 1 | 2014 | 3520 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2014 | 4147 | 0.010 |
Why?
|
Mice, SCID | 2 | 1997 | 2715 | 0.010 |
Why?
|
Recurrence | 1 | 2012 | 8333 | 0.010 |
Why?
|
T-Lymphocytes | 2 | 2014 | 10163 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6534 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2013 | 14554 | 0.010 |
Why?
|
Adolescent | 2 | 2021 | 85649 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2013 | 4933 | 0.010 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 1997 | 370 | 0.010 |
Why?
|
Pneumonia, Viral | 1 | 1995 | 3236 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2011 | 12017 | 0.010 |
Why?
|
Massachusetts | 1 | 2009 | 8662 | 0.010 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 1997 | 304 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 1996 | 326 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2016 | 6454 | 0.010 |
Why?
|
Carbohydrate Sequence | 1 | 1996 | 414 | 0.010 |
Why?
|
Vaccines, Inactivated | 1 | 1996 | 184 | 0.010 |
Why?
|
Complement C3 | 1 | 1997 | 460 | 0.010 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 1 | 1996 | 157 | 0.010 |
Why?
|
Immunization, Passive | 1 | 1997 | 625 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 1995 | 424 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2011 | 7276 | 0.010 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 1995 | 482 | 0.010 |
Why?
|
Antigen-Presenting Cells | 1 | 1996 | 969 | 0.010 |
Why?
|
Immunoglobulin A | 1 | 1995 | 992 | 0.010 |
Why?
|
Viral Vaccines | 1 | 1996 | 636 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 1995 | 1538 | 0.010 |
Why?
|
Epitopes | 1 | 1996 | 2569 | 0.010 |
Why?
|
Killer Cells, Natural | 1 | 1997 | 2133 | 0.000 |
Why?
|
Blotting, Western | 1 | 1996 | 5180 | 0.000 |
Why?
|
Neoplasms | 1 | 2016 | 21596 | 0.000 |
Why?
|
Mice, Inbred BALB C | 1 | 1996 | 6382 | 0.000 |
Why?
|
Child | 1 | 2014 | 77478 | 0.000 |
Why?
|
Immunotherapy, Adoptive | 1 | 1995 | 1255 | 0.000 |
Why?
|
Mutation | 1 | 2010 | 29717 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1996 | 18112 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 1997 | 18006 | 0.000 |
Why?
|